# India

Type: country

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/india-country
Canonical HTML page: https://getbiobrief.com/entity/india-country

## Timeline

- **2026-03-12**: Industry Warning — Polymedicure and industry experts warn of imminent shortages for syringes and IV bags.
- **2026-03-11**: Gas Rationing Implemented — Adani Total Gas limits supply to 40% of contracted quantity for medical device producers.
- **2026-03-01**: Price Surge Acceleration — Raw material costs spike 25-35% within a 10-day window following escalated conflict.
- **2026-02-22**: Formal Announcement — Official confirmation of the bilateral agreement to strengthen medical product regulation.
- **2026-02-21**: MoU Exchange Initiated — Initial diplomatic exchange of the regulatory cooperation framework in New Delhi.
- **2025-12-01**: Initial Price Creep — Polypropylene prices begin a steady climb as Middle East tensions simmer.

## Recent coverage (5 stories)

### Indian Pharma’s 51% Sudan Import Share Drives New Investment Drive
2026-07-11 21:02:09 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

India's 51% share of Sudan's pharmaceutical imports becomes a launchpad for direct investment, with local manufacturing and regulatory collaboration on the table as Sudan recovers from war. The roundtable signals a strategic expansion from generics exports to in-country pharma production.
Full story: https://getbiobrief.com/story/indian-pharma-sudan-investment-51-percent

### Pharma Supply Chains Bolstered in India-Japan 5-Sector Security Pact
2026-07-04 09:29:28 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

The pharmaceutical sector gains a strategic boost as India and Japan agree to cooperate on drug ingredient manufacturing and research. The pact aims to reduce overreliance on Chinese APIs and build resilient supply chains for critical medicines.
Full story: https://getbiobrief.com/story/india-japan-pharma-supply-chain-pact

### India targets 0% pharma supply disruption amid West Asia crisis
2026-06-15 02:26:19 · Sentiment: Bearish · Impact: 6/10 · Sources: 4

Biotech and pharma sectors face supply chain risks from the West Asia situation, but the Indian government claims a multi-pronged strategy will prevent shortages. While concrete fertilizer diversification details are given, pharma-specific mitigation remains less specific, though close monitoring is emphasized.
Full story: https://getbiobrief.com/story/india-pharma-supply-resilience-zero-disruption

### India Medical Device Crisis: Polypropylene Costs Soar Amid Iran Conflict
2026-03-12 04:42:18 · Sentiment: Bearish · Impact: 7/10 · Sources: 2

A critical shortage of medical consumables is looming in India as the Iran war triggers a 35% surge in polypropylene prices and severe gas rationing. These disruptions threaten the production of essential items like syringes and IV bags, primarily impacting the small and medium enterprises that dominate the sector.
Full story: https://getbiobrief.com/story/india-medical-device-polypropylene-shortage-iran-war

### India and Brazil Ink Strategic Regulatory Pact for Pharma and MedTech
2026-02-22 12:33:22 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

India and Brazil have formalized a Memorandum of Understanding (MoU) to harmonize regulatory standards for pharmaceutical and medical products. This bilateral agreement aims to streamline market access and enhance technical cooperation between two of the world's most influential emerging healthcare markets.
Full story: https://getbiobrief.com/story/india-brazil-pharma-regulatory-mou-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.